Skip to main content

Advertisement

SpringerLink
Log in

Impaired metabolism of methionine in severe liver diseases I. Clinical and pathophysiological significance of elevated serum methionine levels

  • Original Articles
  • Published:
Gastroenterologia Japonica Aims and scope Submit manuscript

Summary

Serum methionine levels increased to a greater extent in patients with severe liver diseases such as fulminant hepatitis and liver cirrhosis with and without hepatic encephalopathy. However, the concentrations remained unchanged in non-encephalopathic cirrhotic cases associated with hepatocellular carcinoma, and their serum methionine levels increased only moderately even at the time of encephalopathy. At least two different mechanisms of serum methionine elevations, possibly due to release from injured hepatocytes or diminished catabolisms of this amino acid in the damaged liver, could be differentiated; the former would be involved mainly in fulminant hepatitis and the latter in liver cirrhosis. A methionine-loading test performed in cirrhotic patients supported the validity of these considerations. No significant increase of serum methionine levels in cirrhotic patients with hepatocellular carcinoma was observed, possibly by remarkable consumption of this amino acid in hepatoma tissues. During the clinical course of several patients, serial determinations of serum methionine concentrations indicated that the levels varied depending upon alterations in the pathophysiological state of the damaged liver; much higher levels were observed concomitantly with decompensated signs such as ascites, jaundice and hepatic encephalopathy. These results suggest that monitoring of serum methionine levels would be very valuable, especially for judging prognosis and predicting hepatic encephalopathy in severe liver disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Fischer JE, et al: Plasma amino acid in patient with hepatic encephalopathy -Effect of amino acid solution. Am J Surg 127: 40, 1974

    Article  PubMed  CAS  Google Scholar 

  2. Record CO, et al: Plasma and brain amino acids in fulminant hepatic failure and their relationship to hepatic encephalopathy. Europ J Clin Invest 6: 387, 1976

    PubMed  CAS  Google Scholar 

  3. Watanabe A, et al: Serum amino acids in hepatic encephalopathy -Effect of branched-chain amino acid infusion of serum aminogram. Acta Hepato-Gastroenterol 26:36, 1979

    Google Scholar 

  4. Shults WT, et al: Methanethiol poisoning. JAMA 211: 2153, 1970

    Article  PubMed  CAS  Google Scholar 

  5. Zieve L, et al: Synergism between marcaptans and ammonia or fatty acids in the production of coma: A possible role for mercaptans in pathogenesis of hepatic coma. J Lab Clin Med 83: 16, 1974

    PubMed  CAS  Google Scholar 

  6. Merino GE, et al: Methionine-induced hepatic coma in dogs. Am J Surg 130: 41, 1975

    Article  PubMed  CAS  Google Scholar 

  7. Kosaka K: Symposium (I) Fulminant hepatitis. Jpn J Gastroenterol 68: 855, 1971

    Google Scholar 

  8. Sherlock S: Hepato-cellular failure, in “Diseases of the liver and biliary system” Vol 5, Asian edition, by Sherlock S, Tokyo, 1975, p 87

    Google Scholar 

  9. Watanabe A, et al: An approach to nutritional therapy of hepatic encephalopathy by normalization of deranged amino acid patterns in serum. Acta Med Okayama 32: 427, 1978

    PubMed  CAS  Google Scholar 

  10. Watanabe A, et al: A rapid method for monitoring serum neutral amino acid concentrations in severe liver diseases. Hepato-Gastroenterol 28: 17, 1981

    CAS  Google Scholar 

  11. Higashi T, et al: Impaired metabolism of methionine in patients with severe liver disease (3) -Clinical significance of an intravenous methionine-loading test. Jpn J Gastroenterol 76: 546, 1979

    Google Scholar 

  12. Kunin CM, et al: Persistence of antibiotics in blood of patients with acute renal failure. II. Chloramphenicol and its metabolic products in the blood of patients with severe renal disease or hepatic cirrhosis. J Clin Invest 38: 1498, 1959

    PubMed  CAS  Google Scholar 

  13. Higashi T, et al: Clinical experimental studies on characteristic features of serum aminogram in cirrhotic patients with primary hepatoma and in rats with ethionine-induced hepatoma. Acta Hep Jpn 21: 1196, 1980

    Google Scholar 

  14. Felig P, et al: Amino acid metabolism during prolonged starvation. J Clin Invest 48: 584, 1969

    Article  PubMed  CAS  Google Scholar 

  15. Brodam V, et al: The effect of glucagon on free plasma amino acids in cirrhotics and healthy controls. Acta Hepato-Gastroenterol 25: 23, 1978

    Google Scholar 

  16. Goldberg AL, et al: Regulation and significance of amino acid metabolism in skeletal muscle. Fed Proc 37: 2301, 1978

    PubMed  CAS  Google Scholar 

  17. Sherwin R, et al: Hyperglucagonemia in Laennec’s cirrhosis. The role of portal-systemic shunting. New Engl J Med 290: 239, 1974

    Article  PubMed  CAS  Google Scholar 

  18. Watanabe A, et al: Clinical significance of branchedchain amino acid infusion during treatment of patients with fulminant hepatitis. Acta Hep Jpn 20: 702, 1979

    Google Scholar 

  19. Aguirre A, et al: Plasma amino acids in dogs with two experimental forms of liver damage. J Surg Res 16: 339, 1974

    Article  PubMed  CAS  Google Scholar 

  20. Rosen HM, et al: Plasma amino acid patterns in hepatic encephalopathy of differing etiology. Gastroenterology 72: 483, 1977

    PubMed  CAS  Google Scholar 

  21. Cantoni GL: S-Adenosylmethionine: Present status and future perspectives. The biochemistry of adenosylmethionine by Salvatore F, Borek E, Zappia V, Williams-Ashman HG, Schlenk F. Columbia University Press, New York, 1977, p 558

    Google Scholar 

  22. Gaull GE, et al: Methionine-adenosyl transferase deficiency: New enzymatic defect associated with hypermethionemia: Science 186: 59, 1974

    CAS  Google Scholar 

  23. Gaull GE, et al: Biochemical observation so-called hereditary tyrosinemia. Pediat Res 4: 337, 1970

    PubMed  CAS  Google Scholar 

  24. Smuckler EA, et al: Cellular adenosine triphosphate levels in liver and kidney during CCl4 intoxication. Lab Invest 19: 218, 1968

    CAS  Google Scholar 

  25. Labadarious D, et al: Vitamin B6 deficiency in chronic liver disease -Evidence for increased degradation of pyridoxal-5’-phosphate. Gut 18: 23, 1977

    Article  Google Scholar 

  26. Goseki K, et al: Combined therapy of anticancer agents and total parenteral nutrition using methionine-deficiency amino acid solution for gastrointestinal tumor. Jpn J Gastroenterol 78: 629, 1981

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The First Department of Internal Medicine, Okayama University Medical School, 5-1, Shikata-cho, 2 chome, 700, Okayama, Japan

    Toshihiro Higashi M.D.

Authors
  1. Toshihiro Higashi M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Higashi, T. Impaired metabolism of methionine in severe liver diseases I. Clinical and pathophysiological significance of elevated serum methionine levels. Gastroenterol Jpn 17, 117–124 (1982). https://doi.org/10.1007/BF02774550

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02774550

Key Words

Search

Navigation